| 标题 |
AJ1-11095, a potent and highly selective type-II JAK2 inhibitor, shows enhanced therapeutic efficacy as compared with type-I JAK2 inhibitor ruxolitinib in models of myeloproliferative neoplasms (MPNs) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Blood 作者:Marc Usart; Shivam Rai; Kavi O'Connor; Quentin Kimmerlin; Zachary Zaroogian; et al 出版日期:2025 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)